Objective: To review systematically the association between hormone replacement therapy
(HRT) and the risk of developing or dying from colorectal cancer. Data Sources: We …

PURPOSE: Colorectal cancer is the fourth most common cancer and the second leading
cause of cancer death in the United States. Accumulating evidence indicates that …

Little is known about the effects of various types, modes, and routes of hormone replacement
therapy (HRT) on the risk of colorectal cancer (CRC) among postmenopausal women. We …

The influence of endocrine factors on colorectal tumor development remains unclear. We
performed a meta-analysis of studies of the association between the use of menopausal …

The hypothesis that sex hormones may influence colorectal cancer risk was formulated in
the early 1980s, but epidemiological studies on a relationship between colorectal cancer …

Colorectal cancer is the third leading cause of cancer death in women. Studies on the
potential protective effect of postmenopausal hormone replacement on the incidence of …

Purpose Estrogen/progestin replacement therapy is prescribed to women in menopause for
purposes of postmenopausal symptom control or prevention of hormone deficiency–related …

Introduction: Colorectal cancer is the second leading cause of cancer death among US men
and women. A number of studies report that hormone replacement therapy (HRT) reduces …

Background Hormone replacement therapy (HRT) use has shown to be associated with a
reduced risk of colorectal cancer, however, its impact on survival among women with …

Background: The epidemiology of large-bowel cancer suggests a role for endocrine factors
in its development. Although analytic studies have not consistently provided evidence for an …